News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,777 Results
Type
Article (45494)
Company Profile (321)
Press Release (693962)
Multimedia
Podcasts (86)
Webinars (13)
Section
Business (216257)
Career Advice (2262)
Deals (37521)
Drug Delivery (115)
Drug Development (84615)
Employer Resources (178)
FDA (17178)
Job Trends (15882)
News (365922)
Policy (35317)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (5)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (8)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (8)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2684)
Accelerated approval (6)
Adcomms (23)
Allergies (88)
Alliances (53171)
ALS (92)
Alzheimer's disease (1406)
Antibody-drug conjugate (ADC) (127)
Approvals (17169)
Artificial intelligence (268)
Autoimmune disease (23)
Automation (15)
Bankruptcy (377)
Best Places to Work (12054)
BIOSECURE Act (19)
Biosimilars (114)
Biotechnology (199)
Bladder cancer (62)
Brain cancer (28)
Breast cancer (270)
Cancer (2156)
Cardiovascular disease (179)
Career advice (1894)
Career pathing (31)
CAR-T (157)
Cell therapy (432)
Cervical cancer (19)
Clinical research (68577)
Collaboration (835)
Compensation (516)
Complete response letters (27)
COVID-19 (2733)
CRISPR (43)
C-suite (234)
Cystic fibrosis (104)
Data (2083)
Decentralized trials (2)
Denatured (32)
Depression (44)
Diabetes (275)
Diagnostics (6607)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (113)
Drug shortages (30)
Duchenne muscular dystrophy (94)
Earnings (90097)
Editorial (39)
Employer branding (21)
Employer resources (153)
Events (118408)
Executive appointments (719)
FDA (18410)
Featured Employer (55)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (745)
Gene editing (108)
Generative AI (22)
Gene therapy (316)
GLP-1 (776)
Government (4702)
Grass and pollen (5)
Guidances (51)
Healthcare (19520)
Huntington's disease (24)
IgA nephropathy (25)
Immunology and inflammation (125)
Indications (27)
Infectious disease (2878)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (93)
Interviews (355)
IPO (17117)
IRA (48)
Job creations (4268)
Job search strategy (1617)
Kidney cancer (9)
Labor market (36)
Layoffs (504)
Leadership (18)
Legal (8727)
Liver cancer (76)
Lung cancer (308)
Lymphoma (141)
Machine learning (5)
Management (62)
Manufacturing (313)
MASH (65)
Medical device (14136)
Medtech (14141)
Mergers & acquisitions (20919)
Metabolic disorders (709)
Multiple sclerosis (76)
NASH (17)
Neurodegenerative disease (94)
Neuropsychiatric disorders (26)
Neuroscience (1943)
NextGen: Class of 2025 (6851)
Non-profit (4597)
Northern California (2575)
Now hiring (38)
Obesity (384)
Opinion (246)
Ovarian cancer (74)
Pain (90)
Pancreatic cancer (81)
Parkinson's disease (151)
Partnered (21)
Patents (232)
Patient recruitment (101)
Peanut (49)
People (60586)
Pharmaceutical (100)
Pharmacy benefit managers (19)
Phase I (21316)
Phase II (30129)
Phase III (22598)
Pipeline (1138)
Policy (145)
Postmarket research (2712)
Preclinical (9036)
Press Release (72)
Prostate cancer (101)
Psychedelics (32)
Radiopharmaceuticals (258)
Rare diseases (396)
Real estate (6535)
Recruiting (68)
Regulatory (24019)
Reports (46)
Research institute (2430)
Resumes & cover letters (377)
Rett syndrome (4)
RNA editing (4)
RSV (45)
Schizophrenia (74)
Series A (130)
Series B (85)
Service/supplier (15)
Sickle cell disease (55)
Southern California (2212)
Special edition (16)
Spinal muscular atrophy (153)
Sponsored (32)
Startups (3881)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (27)
The Weekly (52)
United States (22667)
Vaccines (727)
Venture capitalists (39)
Weight loss (265)
Women's health (36)
Worklife (16)
Date
Today (4)
Last 7 days (487)
Last 30 days (2293)
Last 365 days (33963)
2025 (9554)
2024 (36507)
2023 (41413)
2022 (52684)
2021 (57410)
2020 (56015)
2019 (48808)
2018 (36860)
2017 (34280)
2016 (33968)
2015 (39981)
2014 (33770)
2013 (28927)
2012 (31111)
2011 (31720)
2010 (29590)
Location
Africa (821)
Alabama (52)
Alaska (7)
Arizona (249)
Arkansas (14)
Asia (42761)
Australia (6924)
California (5890)
Canada (1962)
China (507)
Colorado (262)
Connecticut (273)
Delaware (141)
Europe (92306)
Florida (867)
Georgia (205)
Hawaii (1)
Idaho (60)
Illinois (547)
India (26)
Indiana (318)
Iowa (9)
Japan (154)
Kansas (106)
Kentucky (25)
Louisiana (10)
Maine (70)
Maryland (890)
Massachusetts (4468)
Michigan (236)
Minnesota (392)
Mississippi (2)
Missouri (85)
Montana (29)
Nebraska (25)
Nevada (60)
New Hampshire (65)
New Jersey (1707)
New Mexico (29)
New York (1676)
North Carolina (998)
North Dakota (8)
Northern California (2575)
Ohio (198)
Oklahoma (14)
Oregon (39)
Pennsylvania (1325)
Puerto Rico (11)
Rhode Island (30)
South America (1237)
South Carolina (20)
South Dakota (1)
Southern California (2212)
Tennessee (99)
Texas (886)
Utah (179)
Virginia (149)
Washington D.C. (61)
Washington State (552)
West Virginia (3)
Wisconsin (53)
739,777 Results for "tap pharmaceutical products inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hamamatsu Photonics and Sirona Dx (SDX) Announce Strategic Partnership to Expand Technology Access Program (TAP)
April 14, 2025
·
3 min read
Press Releases
Watchmaker Genomics Advances TAPS Commercialization with Achievement of Key Technology Transfer Milestone
February 26, 2025
·
3 min read
Press Releases
Discure Technologies Accepted into FDA TAP Program for Its Breakthrough Device for Degenerative Disc Disease
March 4, 2025
·
2 min read
Press Releases
Phantom Neuro Receives FDA Breakthrough Device and TAP Designations, Solidifying Position as a Neurotech Leader
March 6, 2025
·
3 min read
Press Releases
Cala Presents Multiple Clinical Studies Demonstrating Impact of Transcutaneous Afferent Patterned Stimulation (TAPS) Therapy in Essential Tremor (ET) Patients at the American Academy of Neurology (AAN)
April 7, 2025
·
5 min read
Biotech Bay
Simpson Interventions Accepted into FDA’s TAP Pilot Program for Breakthrough Device, Acolyte™ Catheter System
Simpson Interventions, Inc., a pioneering medical technology company specializing in cardiovascular interventional devices, today announced its acceptance into the Total Product Life Cycle Advisory Program Pilot (TAP Pilot) by the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA).
May 15, 2024
·
2 min read
Parkinson’s disease
Supernus Taps Potential $300M US Opportunity With FDA Win for Parkinson’s Drug-Device Combo
Before garnering approval on Tuesday, Onapgo had been rejected twice by the FDA.
February 5, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Biogen Taps Royalty Pharma for $250M to Power Phase III Lupus Program
The funding agreement comes as Biogen revealed a modest Q4 sales beat, which analysts expect will be “overshadowed” by the company’s forecasted dip in 2025 revenues.
February 12, 2025
·
2 min read
·
Tristan Manalac
Policy
RFK Jr. to Cut 10,000 Jobs Across HHS
The announcement by the Department of Health and Human Services highlighted a flurry of moves, which include the shifting of departments. Also this week, HHS Secretary Robert F. Kennedy Jr. tapped fellow vaccine critic David Geier to investigate vaccine safety within the CDC.
March 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
OrthoPreserve Receives Both FDA Breakthrough Device Designation and Prestigious TAP Enrollment for Meniscus Implant to Revolutionize Knee Pain Treatment
January 30, 2025
·
3 min read
1 of 73,978
Next
